Cancer Tissue Diagnostics Market to 2027 - Global Analysis and Forecasts By Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Geography

THE3243820
159 Pages
July 2019
Medical Devices

Download Sample Get Discount

The global cancer tissue diagnostics market is expected to reach US$ 3,419.61 Mn in 2027 from US$ 2,025.41 in 2018. The market is estimated to grow with a CAGR of 6.2% from 2019-2027.

The market for cancer tissue diagnostics is expected to grow, owing to factors such as growing cancer prevalence across the globe, new product launches & FDA approvals and growing investments for tissue diagnostics are boosting the market over the years. In addition, the emerging markets in developing countries are likely to have a positive impact on the growth of the market in the coming years. However, factors such as high cost of cancer diagnostics are likely to have a negative impact on the growth of the market in the coming years.

Cancer tissue diagnostic techniques are used to detect the tumor in the malignant tissues. In the last few years, immunohistochemistry (IHC) was used to increase the detection of specific antigens in the tumor tissue. The screening with the help of nonfluorescent chromogens is analyzed with conventional microscopy. There are recent techniques developed for cancer tissue diagnosis. Fluorescence in situ hybridization, the method is used for examination of a specific genetic abnormality in the genome. The hybridized deoxyribonucleic acid (DNA) is examined with particular probes.

The high cost of cancer diagnostics may restrain the growth of the market during the forecast period. Factors such as high costs involved in diagnosis as well as treatment have a restraining effect on the cancer tissue diagnostic market. Cancer diagnostics tests have become so pricey that ordinary people are unable to afford it. High out-of-pocket costs are barriers to potentially life-saving diagnosis or life-prolonging treatments. These sums up to high diagnosis cost, and thus, patients delay or avoid the diagnosis, which results as a barrier to treatment. According to the study by Marten group, the average out-of-pocket cost of a diagnostic mammogram can be $234 on average, while a breast MRI can cost patients $1,021 on average. Therefore, market players need to focus on developing new products that more cost-efficient than the existing ones in the market to gain potential growth.

Global cancer tissue diagnostics market is segmented by test type. On the basis of test type, the market is segmented into immunohistochemical tests and in situ hybridization tests. On the basis of type, immunohistochemical tests are further sub-segmented into breast cancer, colorectal cancer, prostate cancer, stomach cancer, and others. On the basis of type, in situ hybridization tests is further sub-segmented into breast cancer, lung cancer, bladder cancer, and others. In 2018, the breast cancer segment held the largest share in the market, by immunohistochemical tests.

Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization, Public Health Agency of Canada, International Agency for Research on Cancer, Canadian Breast Cancer Foundation, National Cancer Institute (NCI), National Institute of Cancer Prevention and Research (NICPR), Pancreatic Cancer Network South Africa, and others.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Cancer Tissue Diagnostics Market - By Test Type

1.3.2 Global Cancer Tissue Diagnostics Market - By Geography

2. Global Cancer Tissue Diagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Cancer Tissue Diagnostics Market - Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

5. Global Cancer Tissue Diagnostics Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Growing Cancer Prevalence Across The Globe

5.1.2 New Product Launches & FDA Approvals

5.1.3 Growing Investments For Tissue Diagnostics

5.2 Key Market Restraints

5.2.1 High Cost Of Cancer Diagnostics

5.3 Key Market Opportunities

5.3.1 Emerging Markets in Developing Countries

5.4 Future Trends

5.4.1 Inclination Towards Personalized Medicine

5.5 Impact Analysis

6. Cancer Tissue Diagnostics Market - Global Analysis

6.1 Global Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis

6.2 Global Cancer Tissue Diagnostics Market, By Geography - Forecasts And Analysis

6.3 Performance of Key Players

7. Global Cancer Tissue Diagnostics Market Analysis- by Test Type

7.1 Overview

7.2 Global Cancer Tissue Diagnostics Market, By Test Type 2018 & 2027 (%)

7.3 Immunohistochemical Tests Market

7.3.1 Overview

7.3.2 Global Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.3 Breast Cancer Market

7.3.3.1 Overview

7.3.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.4 Colorectal Cancer Market

7.3.4.1 Overview

7.3.4.2 Global Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.5 Prostate Cancer Market

7.3.5.1 Overview

7.3.5.2 Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.6 Stomach Cancer Market

7.3.6.1 Overview

7.3.6.2 Global Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.7 Others Market

7.3.7.1 Overview

7.3.7.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

7.4 In Situ Hybridization Tests Market

7.4.1 Overview

7.4.2 Global In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.3 Breast Cancer Market

7.4.3.1 Overview

7.4.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.4 Lung Cancer Market

7.4.4.1 Overview

7.4.4.2 Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.5 Bladder Cancer Market

7.4.5.1 Overview

7.4.5.2 Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.6 Others Market

7.4.6.1 Overview

7.4.6.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 - Geographical Analysis

8.1 North America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027

8.1.1 North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.2 North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.1.2.1 North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.2.2 North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.3 North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027, By Country (%)

8.1.4 US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.4.1 US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.4.2 US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.1.4.2.1 US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.4.2.2 US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.5 Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.5.1 Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.5.2 Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.1.5.2.1 Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.5.2.2 Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.6 Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.6.1 Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.6.2 Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.1.6.2.1 Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.6.2.2 Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027

8.2.1 Europe Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.2 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.2.1 Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.2.2 Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.3 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

8.2.4 UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.4.1 UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.4.2 UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.4.2.1 UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.4.2.2 UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.5 Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.5.1 Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.5.2 Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.5.2.1 Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.5.2.2 Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.6 France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.6.1 France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.6.2 France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.6.2.1 France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.6.2.2 France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.7 Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.7.1 Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.7.2 Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.7.2.1 Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.7.2.2 Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.8 Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.8.1 Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.8.2 Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.8.2.1 Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.8.2.2 Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027

8.3.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.2 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.2.1 Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.2.2 Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

8.3.4 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.4.1 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.4.2 Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.4.2.1 Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.4.2.2 Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.5 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.5.1 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.5.2 China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.5.2.1 China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.5.2.2 China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.6 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.6.1 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.6.2 India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.6.2.1 India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.6.2.2 India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.7 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.7.1 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.7.2 South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.7.2.1 South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.7.2.2 South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.8 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.8.1 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.8.2 Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.8.2.1 Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.8.2.2 Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027

8.4.1 Middle East & Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.2 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.4.2.1 Middle East & Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.2.2 Middle East & Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.3 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

8.4.4 UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4.1 UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4.2 UAE Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.4.4.2.1 UAE Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.4.2.2 UAE In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.4.3 Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4.4 Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4.5 Saudi Arabia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.4.4.5.1 Saudi Arabia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.4.5.2 Saudi Arabia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.5 South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.5.1 South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.5.2 South Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.4.5.2.1 South Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.5.2.2 South Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5 South And Central America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027

8.5.1 South and Central America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.2 South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.5.2.1 South and Central America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5.2.2 South and Central America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5.3 South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

8.5.4 Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4.1 Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4.2 Argentina Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.5.4.2.1 Argentina Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5.4.2.2 Argentina In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5.4.3 Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4.4 Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4.5 Brazil Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.5.4.5.1 Brazil Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5.4.5.2 Brazil In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9. Cancer Tissue Diagnostics Market- Industry Landscape

9.1 Overview

9.2 Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019

9.3 Organic Growth Strategies

9.3.1 Overview

9.4 Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)

9.4.1 Product Launches

9.4.1.1 Recent Product Launches By Players In The Cancer Tissue Diagnostics Market

9.4.2 Product Approvals

9.4.2.1 Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market

9.4.3 Expansion & Other Activities

9.4.3.1 Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market

9.4.4 Product Enhancements

9.4.4.1 Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market

9.5 Inorganic Growth Strategies

9.5.1 Overview

9.6 Inorganic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)

9.6.1 Agreements

9.6.1.1 Recent Agreements By Players In The Cancer Tissue Diagnostics Market

9.6.2 Partnerships & Collaborations

9.6.2.1 Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market

9.6.3 Acquisitions

9.6.3.1 Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market

10. Cancer Tissue Diagnostics Market-Key Company Profiles

10.1 Bio-Rad Laboratories, Inc.

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Financial Information

10.1.4 Product Portfolio

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Thermo Fisher Scientific, Inc.

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Financial Information

10.2.4 Product Portfolio

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 F. Hoffmann-La Roche Ltd.

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Financial Overview

10.3.4 Product Portfolio

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Abbott

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Financial Overview

10.4.4 Product Portfolio

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Enzo Biochem Inc.

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Financial Overview

10.5.4 Product Portfolio

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 Agilent Technologies, Inc.

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Financial Overview

10.6.4 Product Portfolio

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Cancer Genetics Inc.

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Financial Overview

10.7.4 Product Portfolio

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Merck Kgaa (Sigma-Aldrich)

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Financial Overview

10.8.4 Product Portfolio

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 Abcam Plc.

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Financial Overview

10.9.4 Product Portfolio

10.9.5 SWOT Analysis

10.9.6 Key Developments

10.10 Danaher

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Financial Information

10.10.4 Product Portfolio

10.10.5 SWOT Analysis

10.10.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary Of Terms

LIST OF TABLES

Table 1. North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 2. North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 3. North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 4. US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 5. US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 6. US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 7. Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 8. Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 9. Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 10. Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 11. Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 12. Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 13. Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 14. Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 15. Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 16. UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 17. UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 18. UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 19. Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 20. Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 21. Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 22. France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 23. France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 24. France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 25. Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 26. Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 27. Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 28. Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 29. Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 30. Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 31. Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 32. Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 33. Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 34. Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 35. Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 36. Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 37. China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 38. China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 39. China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 40. India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 41. India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 42. India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 43. South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 44. South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 45. South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 46. Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 47. Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 48. Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 49. Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 50. Middle East & Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 51. Middle East & Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 52. UAE Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 53. UAE Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 54. UAE In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 55. Saudi Arabia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 56. Saudi Arabia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 57. Saudi Arabia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 58. South Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 59. South Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 60. South Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 61. South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 62. South and Central America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 63. South and Central America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 64. Argentina Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 65. Argentina Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 66. Argentina In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 67. Brazil Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 68. Brazil Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 69. Brazil In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 70. Recent Product Launches in the Cancer Tissue Diagnostics Market

Table 71. Recent product Approvals in the Cancer Tissue Diagnostics Market

Table 72. Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market

Table 73. Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market

Table 74. Recent Agreements By Players In The Cancer Tissue Diagnostics Market

Table 75. Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market

Table 76. Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market

Table 77. Glossary of Terms, Cancer Tissue Diagnostics Market

Purchase Options

Single User License $4550 Site User $6550 Enterprise User License $8550

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

Publish Date: August 21, 2016
$5370

View Details

Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

Publish Date: December 1, 2016
$5370

View Details

Laparoscopy Devices Market by Product (Laparoscopes, Energy Devices, Insufflators, Robot-Assisted Surgery Systems, Suction or Irrigation Systems, Closure Devices, Hand Instruments, Access Devices, Accessories, and Other Laparoscopy Devices), Application {General Surgery (Cholecystectomies, Hernia Repairs, Appendectomies, Anti-reflux Surgeries, and Others), Bariatric Surgery (Gastric Bypass, Sleeve gastrectomy, Gastric Banding, and Others), Gynecological Surgery, Urological Surgery, Colorectal Surgery, and Others}, and End User (Hospitals, Clinics, and Other End Users) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...

Publish Date: April 24, 2017
$5370

View Details

Client Testimonials

Your team has worked hard to help and to provide our research needs to fulfill our significant initiatives...

Maria

-Researcher

The report on EAA resins was detailed and informative. However, we were hopeful to discover a Chinese producer ...

David

-President Protech Oxyplast Group

Thanks the attached report is perfect and accurate, but I was wondering if you can show the price trend in one year...

Cancer Tissue Diagnostics Market to 2027 - Global Analysis and Forecasts By Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Geography

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara